POST-MARKET SUMMARY 6th February 2025

On February 6, Indian markets closed lower, dragged down by blue-chip stocks amid weaker earnings. Investor sentiment remained cautious ahead of the Reserve Bank of India's bi-monthly policy announcement on February 7. Sector-wise, Nifty Pharma gained 0.6%, IT rose 0.3%, while Realty declined 2.2%.

NIFTY: The index 65 points higher at 23,761 and made a high of 23,773 before closing at 23,603. Nifty has formed a small bearish candlestick pattern on the daily chart. Its immediate resistance level is now placed at 23,700 while its immediate support is at 23,550. 

BANK NIFTY: The index opened 125 points higher at 50,468 and closed at 50,382. Bank Nifty has formed a Hanging Man candlestick pattern on the daily chart. Its major resistance level is now placed around 50,560 while immediate support is around 50,200.

Stocks in Spotlight

▪  Sagility India: Stock surged over 5% after the company reported impressive Q3FY25 results, with net profit jumping 207% year-on-year to Rs 216.9 crore.

▪  Zydus Lifesciences: Stock gained over 3% after the company reported strong Q3FY25 results, with consolidated net profit rising 30% to Rs 1,023 crore.

▪  Exicom Tele-Systems: Stock tumbled 10%, hitting the lower circuit after the company reported a net loss of Rs 49 crore for Q3FY25.

Global News

▪  European markets were higher on Thursday, with investors assessing more earnings reports and awaiting the latest monetary policy decision from the Bank of England.

▪  Wall Street futures inched higher ahead of corporate earnings, while a pause in U.S. tariff escalations provided some relief to the markets.

▪  The yield on the 10-year U.S. Treasury note was around 4.43% on Thursday, holding at its lowest level since mid-December, as traders assessed the monetary policy outlook.

This document has been issued by Liquide Solutions Private Limited for information purposes only and should not be construed as

i) an offer or recommendation to buy or sell securities, commodities, currencies or other investments referred to herein; or

ii) an offer to sell or a solicitation or an offer for the purchase of any of the baskets of Liquide Solutions; or

iii) investment research or investment advice. It does not have regard to specific investment objectives, financial situation and the particular needs of any specific person who may receive this document. Investors should seek personal and independent advice regarding the appropriateness of investing in any of the funds, securities, other investment, or investment strategies that may have been discussed or referred to herein and should understand that the views regarding future prospects may or may not be realized. In no event shall Liquide Life Private Limited and/or its affiliates or any of their directors, trustees, officers and employees be liable for any direct, indirect, special, incidental or consequential damages arising out of the use of information/opinion herein.

With Liquide, you can explore stocks, trade securely in your own broker account, and receive expert-recommended trade setups. Stay updated with real-time tracking, market commentary, and AI-powered insights from LiMo, our intelligent bot. Whether you're a seasoned investor or a newbie, Liquide provides the tools you need to discover your next big investment opportunity. Download the app now from Google Play Store and Apple App Store to revolutionize your investment journey. Don't miss out on the chance to level up your investing game with Liquide.